Perrigo to Announce Third Quarter 2025 Financial Results on November 5

Perrigo Company plc, a prominent player in the consumer self-care sector, has announced its plans to release financial results for the third quarter of 2025 on November 5, 2025. The announcement was made on October 22, 2025, and includes a scheduled conference call to discuss the results, set to begin at 8:30 A.M. (EST).

The earnings conference call will be accessible to investors and interested parties through a live webcast available in the investor relations section of the Perrigo website. Participants can also join the call by phone at 800-836-8184 for domestic calls or 646-357-8785 for international callers, using reference ID # 03742. Following the live event, a recorded replay will be available starting at approximately 12:00 P.M. (EST) on November 5 and will remain accessible until midnight on November 12, 2025. Individuals wishing to listen to the replay can call 888-660-6345 for domestic access or 646-517-4150 for international access, with the access code 03742#.

About Perrigo and Its Market Position

Perrigo Company plc, headquartered in Dublin, is recognized as a leading self-care company with over a century of experience in delivering high-quality health and wellness solutions. The company primarily serves consumers in North America and Europe, establishing itself as a pioneer in the over-the-counter (OTC) self-care market. Perrigo offers a diverse range of self-care products that do not require a prescription, ensuring that consumers have access to essential healthcare options.

The company’s business model is distinctive, leveraging its strong portfolio of store brand private label offerings to support investments in well-known brands such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. This approach enables Perrigo to maintain its position as a trusted provider in the self-care market, catering to various consumer needs across different dosage forms and value tiers.

Future Outlook and Investor Considerations

As Perrigo prepares to share its financial outcomes, it is important to note that the announcement will include “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. These statements will address potential risks, uncertainties, and factors that could significantly alter the company’s actual performance compared to current expectations.

Investors and interested parties are encouraged to review Perrigo’s filings with the United States Securities and Exchange Commission (SEC), which provide insights into the company’s business operations and financial health. Key information can be found in the “Risk Factors” section of the company’s Form 10-K for the year ending December 31, 2024.

For further inquiries, Bradley Joseph, Vice President of Global Investor Relations and Corporate Communications, can be contacted at (269) 686-3373, while Nicholas Gallagher, Associate Director in the same department, is available at (269) 686-3238.

For more information about Perrigo and its product offerings, visit the official website at www.perrigo.com.